BOIMMG

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4-bisphosphate

BOIMMG ID - 249242

Name - 1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4-bisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](O)[C@H]1O

InChIKey - ADDAOFZXEOIZLT-DGHFDPLFSA-I

Formula - C63H98O19P3

Annotated - ✔

SWISS LIPIDS id - SLM:000428967

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C63H99O16P2	284350	✔
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C63H100O13P	33072	✔
CDP-1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycerol	C66H101N3O15P2	554823	✔
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C63H99O16P2	274614	✔
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(16Z,19Z,22Z,25Z,28Z,31Z-tetratriacontahexaenoyl)-sn-glycero-3-phosphate	C57H89O8P	29484	✔
Acyl-ACP ((16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoate)	C34H55OSR1	749010	✗
1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphate	C23H35O7P	6835	✔
(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoyl-CoA	C55H86N7O17P3S	393	✔
Acyl-ACP ((5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate)	C20H29OSR1	749607	✗
Acyl-Phosphates ((5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate)	C20H31O5P	738485	✗